Cingulate Inc. (CING) Soars on European Patent for ADHD Treatment

Cingulate Inc.’s (CING) shares skyrocketed after the company secured a European patent for its groundbreaking ADHD treatment, CTx-1301. This patent covers a significant portion of Europe, including the UK, solidifying Cingulate’s position in the global ADHD market. The company is also preparing to submit a New Drug Application (NDA) to the FDA, marking a crucial step towards bringing this innovative treatment to US patients.

Kefir: A ‘Superfood’ May Help Alleviate ADHD Symptoms in Children

Dr. Miguel Toribio-Mateas, a renowned neuroscientist, has suggested the consumption of kefir, a fermented milk beverage, as a potential aid in reducing ADHD symptoms in children. Research conducted by Dr. Mateas and his team, published in the BMJ Open journal, examined the impact of kefir on ADHD symptomatology, sleep quality, attention, and gut microbiome composition in children diagnosed with ADHD. The study, which lasted for six weeks, revealed improvements in impulsivity, hyperactivity, and sleep in the participants who consumed kefir daily.

Scroll to Top